DRREDDY's weekly return of 0.83% outperformed its peers, with a relatively higher Sharpe Ratio of 0.19, indicating a better risk-adjusted return. However, the stock's volatility of 24.34% was significantly higher than its peers, making it a riskier investment this week. Despite the higher risk, DRREDDY's performance was relatively strong compared to its peers, with DIVISLAB, SUNPHARMA, and HINDUNILVR all posting negative returns.

[Volatility: 24.34%]